Stay updated on Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.

Latest updates to the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page
- Check5 days agoChange DetectedSite version updated from v3.5.0 to v3.5.2; no changes to study content or visible page functionality.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded Revision: v3.4.3; Deleted Revision: v3.4.2.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded Revision: v3.4.2; removed the funding lapse notice and prior Revision: v3.4.1.SummaryDifference0.2%

- Check76 days agoChange DetectedThe page now includes a site-wide notice about a lapse in government funding and potential delays, and the revision note shows version 3.4.1 (previously 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedA glossary toggle is now shown; the QC criteria label reads 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' capitalization has been adjusted, and the revision label changed to v3.4.0 (replacing v3.3.4).SummaryDifference0.1%

Stay in the know with updates to Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.